Free Trial

Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY) Short Interest Update

Aspen Pharmacare logo with Medical background
Remove Ads

Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY - Get Free Report) saw a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 200 shares, a decrease of 89.5% from the February 28th total of 1,900 shares. Based on an average trading volume of 600 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.0% of the company's shares are sold short.

Aspen Pharmacare Trading Down 1.9 %

Shares of Aspen Pharmacare stock traded down $0.17 during trading hours on Friday, reaching $9.01. The stock had a trading volume of 1,128 shares, compared to its average volume of 625. Aspen Pharmacare has a 1 year low of $8.26 and a 1 year high of $13.69. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.07 and a current ratio of 1.81. The firm has a 50 day simple moving average of $9.40 and a two-hundred day simple moving average of $9.74.

Aspen Pharmacare Company Profile

(Get Free Report)

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.

Read More

Should You Invest $1,000 in Aspen Pharmacare Right Now?

Before you consider Aspen Pharmacare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Pharmacare wasn't on the list.

While Aspen Pharmacare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads